Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

The Vaccine Group completes two deadly disease vaccination projects

7 Dec 2022 13:25

Frontier IP Group PLC The Vaccine Group completes two deadly disease vaccination projects 07.12.2022 / 14:24 CET/CEST The issuer is solely responsible for the content of this announcement.


Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

07.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com


Language:English
Company:Frontier IP Group PLC
United States
ISIN:GB00B63PS212
EQS News ID:1507531
 
End of NewsEQS News Service

1507531 07.12.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS